The need to reduce health care costs, improve outcomes, and increase access to remote care are intensifying the focus on patient care delivery in the home setting. As a result, pharma companies are seeking alternate delivery systems that can provide patient autonomy and mobility while delivering treatment outside of the clinic. Programmable, variable dose on-body injectors provide such options. With the introduction of BD Evolve™ On-body Injector, BD gives pharma companies a wearable solution that is designed to enable new delivery formats in alternate settings. BD Evolve™ enables effective SubQ administration of up to 3 mL of medication. It provides greater flexibility for adjustments to existing formulations and variations in treatment regimens with up to three-day wear, thus allowing for convenient at-home medication delivery which may improve adherence, reduce the cost of delivery, and optimize the standard of care.
BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.
BD, the BD Logo and Evolve are trademarks of Becton, Dickinson and Company or its affiliates © 2022 BD. All rights reserved.